OncoSil Medical Limited (OSL.AX)
AUD 0.01
(25.0%)
AUD 0.01
(25.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -4.43 Million AUD | 51.96% |
| 2023 | -9.22 Million AUD | 15.97% |
| 2022 | -10.97 Million AUD | 6.63% |
| 2021 | -11.75 Million AUD | 43.72% |
| 2020 | -20.88 Million AUD | -171.65% |
| 2019 | -7.68 Million AUD | 49.43% |
| 2018 | -15.2 Million AUD | -90.05% |
| 2017 | -8 Million AUD | 18.2% |
| 2016 | -9.78 Million AUD | -287.7% |
| 2015 | -2.52 Million AUD | 7.9% |
| 2014 | -2.73 Million AUD | 21.98% |
| 2013 | -3.51 Million AUD | -45.57% |
| 2012 | -2.41 Million AUD | 11.58% |
| 2011 | -2.72 Million AUD | -75.8% |
| 2010 | -1.55 Million AUD | -11.21% |
| 2009 | -1.39 Million AUD | 12.63% |
| 2008 | -1.59 Million AUD | -4.1% |
| 2007 | -1.53 Million AUD | 30.4% |
| 2006 | -2.2 Million AUD | -148.32% |
| 2005 | -887.48 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -4.78 Million AUD | 0.0% |
| 2024 Q4 | -4.43 Million AUD | 0.0% |
| 2024 FY | -4.43 Million AUD | 51.96% |
| 2023 FY | -9.22 Million AUD | 15.97% |
| 2023 Q4 | -9.22 Million AUD | 0.0% |
| 2023 Q2 | -5.53 Million AUD | 0.0% |
| 2022 FY | -10.97 Million AUD | 6.63% |
| 2022 Q2 | -6.25 Million AUD | 0.0% |
| 2022 Q4 | -10.97 Million AUD | 0.0% |
| 2021 Q2 | -17.87 Million AUD | 0.0% |
| 2021 Q4 | -11.75 Million AUD | 0.0% |
| 2021 FY | -11.75 Million AUD | 43.72% |
| 2020 FY | -20.88 Million AUD | -171.65% |
| 2020 Q4 | -20.88 Million AUD | 0.0% |
| 2020 Q2 | -6.56 Million AUD | 0.0% |
| 2019 Q4 | -7.68 Million AUD | 0.0% |
| 2019 FY | -7.68 Million AUD | 49.43% |
| 2019 Q2 | -12.97 Million AUD | 0.0% |
| 2018 Q4 | -15.2 Million AUD | 0.0% |
| 2018 Q2 | -5.18 Million AUD | 0.0% |
| 2018 FY | -15.2 Million AUD | -90.05% |
| 2017 Q4 | -8 Million AUD | 0.0% |
| 2017 FY | -8 Million AUD | 18.2% |
| 2017 Q2 | -10.73 Million AUD | 0.0% |
| 2016 Q4 | -9.78 Million AUD | 0.0% |
| 2016 FY | -9.78 Million AUD | -287.7% |
| 2016 Q2 | -2.26 Million AUD | 0.0% |
| 2015 Q2 | -1.6 Million AUD | 0.0% |
| 2015 FY | -2.52 Million AUD | 7.9% |
| 2015 Q4 | -2.52 Million AUD | 0.0% |
| 2014 Q2 | -7.25 Million AUD | 0.0% |
| 2014 FY | -2.73 Million AUD | 21.98% |
| 2014 Q4 | -2.73 Million AUD | 0.0% |
| 2013 Q2 | -2.27 Million AUD | 0.0% |
| 2013 FY | -3.51 Million AUD | -45.57% |
| 2013 Q3 | -3.51 Million AUD | -54.34% |
| 2013 Q4 | -3.51 Million AUD | 0.0% |
| 2013 Q1 | -2.27 Million AUD | 5.68% |
| 2012 FY | -2.41 Million AUD | 11.58% |
| 2012 Q4 | -2.41 Million AUD | 0.0% |
| 2011 FY | -2.72 Million AUD | -75.8% |
| 2011 Q4 | -2.72 Million AUD | 0.0% |
| 2010 FY | -1.55 Million AUD | -11.21% |
| 2010 Q4 | -1.55 Million AUD | 0.0% |
| 2009 Q4 | -1.39 Million AUD | 0.0% |
| 2009 FY | -1.39 Million AUD | 12.63% |
| 2008 FY | -1.59 Million AUD | -4.1% |
| 2008 Q4 | -1.59 Million AUD | 0.0% |
| 2007 Q4 | -1.53 Million AUD | 0.0% |
| 2007 FY | -1.53 Million AUD | 30.4% |
| 2006 FY | -2.2 Million AUD | -148.32% |
| 2006 Q4 | -2.2 Million AUD | 0.0% |
| 2005 FY | -887.48 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 82.615% |
| Adherium Limited | -6.1 Million AUD | 27.417% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -18.243% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -22.962% |
| Anteris Technologies Ltd | -28.49 Million AUD | 84.453% |
| Control Bionics Limited | -19.02 Thousand AUD | -23192.64% |
| CardieX Limited | 2.74 Million AUD | 261.333% |
| Compumedics Limited | 5.08 Million AUD | 187.099% |
| Cochlear Limited | -269.9 Million AUD | 98.358% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 734.237% |
| Cyclopharm Limited | -7.49 Million AUD | 40.917% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 71.781% |
| Nova Eye Medical Limited | -2.8 Million AUD | -58.127% |
| HeraMED Limited | -799.34 Thousand AUD | -454.292% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 130.593% |
| ImpediMed Limited | -23.48 Million AUD | 81.137% |
| InhaleRx Limited | -155.54 Thousand AUD | -2748.535% |
| LBT Innovations Limited | -604 Thousand AUD | -633.564% |
| Micro-X Limited | 826.99 Thousand AUD | 635.76% |
| Neurotech International Limited | -2.11 Million AUD | -109.939% |
| PolyNovo Limited | -30.52 Million AUD | 85.486% |
| Respiri Limited | 413.68 Thousand AUD | 1171.028% |
| SomnoMed Limited | -15.16 Million AUD | 70.779% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 16.464% |
| Uscom Limited | -1.53 Million AUD | -189.47% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -8.518% |